Medtronic plc (NYSE:MDT) Shares Bought by Wallace Advisory Group LLC

Wallace Advisory Group LLC raised its position in Medtronic plc (NYSE:MDT – Free Report) by 102.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,369 shares of the medical technology company’s stock after buying an additional 3,729 shares during [...]

featured-image

Wallace Advisory Group LLC raised its position in Medtronic plc ( NYSE:MDT – Free Report ) by 102.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,369 shares of the medical technology company’s stock after buying an additional 3,729 shares during the quarter.

Wallace Advisory Group LLC’s holdings in Medtronic were worth $580,000 as of its most recent filing with the Securities and Exchange Commission. Several other large investors have also modified their holdings of the company. Wellington Wealth Strategies LLC.



acquired a new position in shares of Medtronic in the 2nd quarter valued at $257,000. NewEdge Advisors LLC grew its position in Medtronic by 7.1% during the 2nd quarter.

NewEdge Advisors LLC now owns 122,880 shares of the medical technology company’s stock worth $9,672,000 after purchasing an additional 8,127 shares during the last quarter. Magnolia Capital Advisors LLC acquired a new position in Medtronic in the second quarter valued at $4,484,000. Creative Planning raised its holdings in shares of Medtronic by 6.

6% in the second quarter. Creative Planning now owns 247,061 shares of the medical technology company’s stock valued at $19,446,000 after buying an additional 15,305 shares during the last quarter. Finally, Susquehanna Fundamental Investments LLC purchased a new stake in shares of Medtronic in the second quarter valued at about $4,745,000.

82.06% of the stock is owned by institutional investors and hedge funds. Medtronic Stock Performance NYSE:MDT opened at $89.

32 on Monday. The firm’s fifty day simple moving average is $85.79 and its 200-day simple moving average is $83.

11. The company has a quick ratio of 1.61, a current ratio of 2.

13 and a debt-to-equity ratio of 0.55. The stock has a market cap of $114.

53 billion, a PE ratio of 32.48, a price-to-earnings-growth ratio of 2.56 and a beta of 0.

84. Medtronic plc has a fifty-two week low of $68.84 and a fifty-two week high of $91.

49. Medtronic Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a $0.

70 dividend. This represents a $2.80 annualized dividend and a yield of 3.

13%. The ex-dividend date of this dividend is Friday, September 27th. Medtronic’s payout ratio is currently 101.

82%. Analyst Ratings Changes A number of equities analysts recently issued reports on MDT shares. Barclays raised their price target on Medtronic from $104.

00 to $105.00 and gave the stock an “overweight” rating in a report on Thursday, August 22nd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $92.

00 target price on shares of Medtronic in a research note on Wednesday, August 21st. Robert W. Baird upped their price target on Medtronic from $82.

00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. Needham & Company LLC reiterated a “hold” rating on shares of Medtronic in a research report on Tuesday, August 20th.

Finally, Truist Financial boosted their price objective on shares of Medtronic from $85.00 to $90.00 and gave the company a “hold” rating in a research note on Friday, August 23rd.

One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $92.

92. Check Out Our Latest Report on MDT Medtronic Company Profile ( Free Report ) Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Featured Articles Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter ..